TRADE-Testosterone Replacement and Dutasteride Effectiveness

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

April 30, 2010

Study Completion Date

December 31, 2010

Conditions
HypogonadismBenign Prostatic Hyperplasia
Interventions
DRUG

Dutasteride

Dutasteride 0.5 mg orally daily

DRUG

Testosterone gel

Testosterone gel 7.5 g daily topical

DRUG

Placebo dutasteride

placebo dutasteride orally daily

Trial Locations (1)

98108

VA Puget Sound Health Care System, Seattle

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Seattle Institute for Biomedical and Clinical Research

OTHER

collaborator

VA Office of Research and Development

FED

collaborator

Solvay Pharmaceuticals

INDUSTRY

lead

University of Washington

OTHER

NCT00194675 - TRADE-Testosterone Replacement and Dutasteride Effectiveness | Biotech Hunter | Biotech Hunter